| Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization D Planas, D Veyer, A Baidaliuk, I Staropoli, F Guivel-Benhassine, ... Nature 596 (7871), 276-280, 2021 | 2344 | 2021 |
| Considerable escape of SARS-CoV-2 Omicron to antibody neutralization D Planas, N Saunders, P Maes, F Guivel-Benhassine, C Planchais, ... Nature 602 (7898), 671-675, 2022 | 1512 | 2022 |
| IgA dominates the early neutralizing antibody response to SARS-CoV-2 D Sterlin, A Mathian, M Miyara, A Mohr, F Anna, L Claër, P Quentric, ... Science translational medicine 13 (577), eabd2223, 2021 | 1069 | 2021 |
| Sensitivity of infectious SARS-CoV-2 B. 1.1. 7 and B. 1.351 variants to neutralizing antibodies D Planas, T Bruel, L Grzelak, F Guivel-Benhassine, I Staropoli, F Porrot, ... Nature medicine 27 (5), 917-924, 2021 | 777 | 2021 |
| Syncytia formation by SARS‐CoV‐2‐infected cells J Buchrieser, J Dufloo, M Hubert, B Monel, D Planas, MM Rajah, ... The EMBO journal 39 (23), e106267, 2020 | 455 | 2020 |
| A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations L Grzelak, S Temmam, C Planchais, C Demeret, L Tondeur, C Huon, ... Science translational medicine 12 (559), eabc3103, 2020 | 361* | 2020 |
| CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses B Descours, G Petitjean, JL López-Zaragoza, T Bruel, R Raffel, C Psomas, ... Nature 543 (7646), 564-567, 2017 | 296 | 2017 |
| Serum neutralization of SARS-CoV-2 Omicron sublineages BA. 1 and BA. 2 in patients receiving monoclonal antibodies T Bruel, J Hadjadj, P Maes, D Planas, A Seve, I Staropoli, ... Nature medicine 28 (6), 1297-1302, 2022 | 291 | 2022 |
| Elimination of HIV-1-infected cells by broadly neutralizing antibodies T Bruel, F Guivel-Benhassine, S Amraoui, M Malbec, L Richard, K Bourdic, ... Nature communications 7 (1), 10844, 2016 | 254* | 2016 |
| Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection F Gallais, P Gantner, T Bruel, A Velay, D Planas, MJ Wendling, S Bayer, ... EBioMedicine 71, 2021 | 251* | 2021 |
| IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread AA Compton, T Bruel, F Porrot, A Mallet, M Sachse, M Euvrard, C Liang, ... Cell host & microbe 16 (6), 736-747, 2014 | 250 | 2014 |
| SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance R Robinot, M Hubert, GD de Melo, F Lazarini, T Bruel, N Smith, ... Nature communications 12 (1), 1-16, 2021 | 223 | 2021 |
| Cluster of COVID-19 in northern France: a retrospective closed cohort study A Fontanet, L Tondeur, Y Madec, R Grant, C Besombes, N Jolly, ... MedRxiv, 2020.04. 18.20071134, 2020 | 203 | 2020 |
| Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers S Marot, I Malet, V Leducq, K Zafilaza, D Sterlin, D Planas, A Gothland, ... Nature communications 12 (1), 844, 2021 | 191 | 2021 |
| Resistance of Omicron subvariants BA. 2.75. 2, BA. 4.6, and BQ. 1.1 to neutralizing antibodies D Planas, T Bruel, I Staropoli, F Guivel-Benhassine, F Porrot, P Maes, ... Nature communications 14 (1), 824, 2023 | 174 | 2023 |
| Zika virus induces massive cytoplasmic vacuolization and paraptosis‐like death in infected cells B Monel, AA Compton, T Bruel, S Amraoui, J Burlaud‐Gaillard, N Roy, ... The EMBO journal 36 (12), 1653-1668, 2017 | 160 | 2017 |
| Distinct systemic and mucosal immune responses during acute SARS-CoV-2 infection N Smith, P Goncalves, B Charbit, L Grzelak, M Beretta, C Planchais, ... Nature immunology 22 (11), 1428-1439, 2021 | 149 | 2021 |
| Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France S Fafi-Kremer, T Bruel, Y Madec, R Grant, L Tondeur, L Grzelak, ... EBioMedicine 59, 2020 | 131 | 2020 |
| Sex differences in the evolution of neutralizing antibodies to severe acute respiratory syndrome coronavirus 2 L Grzelak, A Velay, Y Madec, F Gallais, I Staropoli, C Schmidt-Mutter, ... The Journal of infectious diseases 224 (6), 983-988, 2021 | 107 | 2021 |
| Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study J Rosado, S Pelleau, C Cockram, SH Merkling, N Nekkab, C Demeret, ... The Lancet Microbe 2 (2), e60-e69, 2021 | 102 | 2021 |
Jérémy DuflooMSCA Postdoctoral Fellow, I2SysBio, Universidad de ValenciaDirección de correo verificada de uv.es